Interviews
A New Approach To Pharmacovigilance
1.Quanticate has just completed an investment initiative to upgrade its pharmacovigilance safety data base,how will the new system simplify event reporting in the EU...
News
KP415 Phatmacokinetic Single And Multiple Dose Trial Preliminary Results Announced By KemPharm
KemPharm, Inc. , a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced preliminary results of KP415.109. ...
Press Releases
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal...
Press Releases
Clinerion announces a new technology for patient identification using fully anonymized electronic patient data
Clinerion has filed an international patent application following the PCT route for a new technology for patient search and identification based on the electronic...
Industry Reports
Mundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1
The Mundipharma network of independent associated companies announced that it has acquired from CellAct the worldwide development, commercialization and manufacturing rights to CAP7.1. ...
Industry Reports
IFM Therapeutics To Be Acquired by Bristol- Myers Squibb To Strengthen Oncology Pipeline Focus On Innate Immunity
Bristol-Myers Squibb Company and IFM Therapeutics announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the...
Press Releases
The Great Hall of China: double digit growth at CPhI China
P-MEC China, CPHI china , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read